1. Home
  2. CTS vs NVAX Comparison

CTS vs NVAX Comparison

Compare CTS & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTS
  • NVAX
  • Stock Information
  • Founded
  • CTS 1896
  • NVAX 1987
  • Country
  • CTS United States
  • NVAX United States
  • Employees
  • CTS N/A
  • NVAX N/A
  • Industry
  • CTS Electrical Products
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CTS Technology
  • NVAX Health Care
  • Exchange
  • CTS Nasdaq
  • NVAX Nasdaq
  • Market Cap
  • CTS 1.3B
  • NVAX 1.3B
  • IPO Year
  • CTS N/A
  • NVAX 1995
  • Fundamental
  • Price
  • CTS $41.89
  • NVAX $6.84
  • Analyst Decision
  • CTS
  • NVAX Buy
  • Analyst Count
  • CTS 0
  • NVAX 5
  • Target Price
  • CTS N/A
  • NVAX $16.60
  • AVG Volume (30 Days)
  • CTS 189.0K
  • NVAX 4.9M
  • Earning Date
  • CTS 07-29-2025
  • NVAX 08-07-2025
  • Dividend Yield
  • CTS 0.37%
  • NVAX N/A
  • EPS Growth
  • CTS 16.02
  • NVAX N/A
  • EPS
  • CTS 1.97
  • NVAX 2.97
  • Revenue
  • CTS $515,789,999.00
  • NVAX $1,254,962,000.00
  • Revenue This Year
  • CTS $4.41
  • NVAX $56.85
  • Revenue Next Year
  • CTS $7.00
  • NVAX N/A
  • P/E Ratio
  • CTS $21.25
  • NVAX $2.30
  • Revenue Growth
  • CTS N/A
  • NVAX 25.92
  • 52 Week Low
  • CTS $34.02
  • NVAX $5.01
  • 52 Week High
  • CTS $59.68
  • NVAX $17.81
  • Technical
  • Relative Strength Index (RSI)
  • CTS 45.85
  • NVAX 51.12
  • Support Level
  • CTS $42.39
  • NVAX $6.54
  • Resistance Level
  • CTS $43.65
  • NVAX $7.20
  • Average True Range (ATR)
  • CTS 1.06
  • NVAX 0.28
  • MACD
  • CTS -0.16
  • NVAX 0.06
  • Stochastic Oscillator
  • CTS 24.94
  • NVAX 66.36

About CTS CTS Corporation

CTS Corp operates in the electronics industry. The company is a manufacturer of Sensors, Electronic components, and Actuators. It designs, manufactures, and sells a broad line of sensors, electronic components, and actuators mainly to original equipment manufacturers (OEM) for the aerospace and defense, industrial, information technology, medical, telecommunications, and transportation markets. Geographically, it derives a majority of its revenue from the United States and also has a presence in China; Singapore; the Czech Republic; Taiwan, Denmark, and other countries.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: